Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Pediatr Pulmonol. 2022 Sep 23;57(12):3165–3168. doi: 10.1002/ppul.26143

TABLE 2.

Radon exposure and respiratory outcomes

Radon exposure duration Asthma diagnosis Noisy breathing Nighttime difficulty breathing Nocturnal cough Missed school days
N 3242 3192 3188 3228 3225
1 month moving average 1.86 (1.16–2.99)* 1.27 (0.81–2.01) 1.08 (0.60–1.95) 1.02 (0.66–1.57) 2.25 (1.23–4.15)**
5 month moving average 1.97 (1.25–3.11)** 1.46 (0.94–2.26) 1.23 (0.70–2.18) 1.18 (0.78–1.78) 2.37 (1.32–4.28)**
7 month moving average 1.89 (1.19–2.99)** 1.40 (0.90–2.18) 1.21 (0.68–2.14) 1.12 (0.74–1.70) 2.23 (1.2–4.05)**
12 month moving average 1.65 (1.00–2.73) 1.16 (0.72–1.88) 1.03 (0.55–1.92) 0.96 (0.61–1.51) 2.00 (1.04–3.83)*
24 month moving average 1.72 (0.99–3.00) 1.19 (0.70–2.02) 1.02 (0.51–2.02) 1.01 (0.61–1.66) 2.25 (1.10–4.60)*

Note: Logistic regression analysis adjusted for age, race, cohort, and year. Data are presented as odds ratio and 95% confidence interval.

*

p < 0.05

**

p < 0.01.